Search

Showing "11155" results for ""

Low birth weight seen in small minority of infants exposed to some antiretroviral drugs

Microbicides – where next?

Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy

Malawi plans 'test and treat' approach for pregnant women to cut mother-to-child HIV transmission

Immigrants are more risk of HIV in their host country than back at home

People with HIV/hepatitis C co-infection more likely to develop osteoporosis

The future of AIDS activism: looking for sustained energy and new tactics 10 years after Durban

Incentives and phone follow-up could improve healthy behaviour by young people: more research needed

Hepatitis C epidemic in HIV-positive gay men in Netherlands seems to have levelled off

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

Early treatment for infants cheaper than delaying treatment, CHER study shows

Ugandan study shows why human rights are central to HIV prevention with African men who have sex with men

Experimental integrase inhibitor GSK-572 shows continued promise

Once-daily extended-release nevirapine works as well as twice-daily formulation

Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV

Penal reform, decriminalisation of illicit drugs, and increased advocacy all central to improving prisoners' health

UK: one in six gay men testing HIV-positive were infected recently

Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result

Receive the latest HIV research and conference news

Showing "11155" results for ""

Low birth weight seen in small minority of infants exposed to some antiretroviral drugs

Microbicides – where next?

Protease inhibitor to raltegravir switch maintains viral suppression, but NRTI resistance lowers efficacy

Malawi plans 'test and treat' approach for pregnant women to cut mother-to-child HIV transmission

Immigrants are more risk of HIV in their host country than back at home

People with HIV/hepatitis C co-infection more likely to develop osteoporosis

The future of AIDS activism: looking for sustained energy and new tactics 10 years after Durban

Incentives and phone follow-up could improve healthy behaviour by young people: more research needed

Hepatitis C epidemic in HIV-positive gay men in Netherlands seems to have levelled off

Rilpivirine (TMC278) matches efavirenz in phase 3 studies, with fewer side-effects

Early treatment for infants cheaper than delaying treatment, CHER study shows

Ugandan study shows why human rights are central to HIV prevention with African men who have sex with men

Experimental integrase inhibitor GSK-572 shows continued promise

Once-daily extended-release nevirapine works as well as twice-daily formulation

Starting ART two weeks after TB treatment reduces death risk by one-third in people with HIV

Penal reform, decriminalisation of illicit drugs, and increased advocacy all central to improving prisoners' health

UK: one in six gay men testing HIV-positive were infected recently

Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result

Receive the latest HIV research and conference news